Overview

WP2 bridges the gap between commercial innovation and regulatory approval. We work with industry partners to streamline the certification and accreditation process for new pharmacogenomic assays.

Key Objectives

• Gap Analysis: Conducting comprehensive reviews of current industry and regulatory hurdles.
• Regulatory Portal: Designing a central hub to facilitate guidance and streamline testing approval.
• Assay Accreditation: Defining efficient pathways for commercial assay certification.

Related Resources

• About CERSI-PGx
• Regulatory Science and Pharmacogenomics

Leads